Publications by authors named "Varun M Kumar"

Claim this Profile
D
Does Cost-Effectiveness Analysis Overvalue Potential Cures? Exploring Alternative Methods for Applying a "Shared Savings" Approach to Cost Offsets.
Richard H Chapman, Varun M Kumar, Melanie D Whittington, Steven D Pearson

Value Health· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in US.
Praveen Thokala, Matt Stevenson, Varun M Kumar, Shijie Ren, Alexandra G Ellis

Cost Eff Resour Alloc· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States".
R Brett McQueen, Melanie D Whittington, Rick H Chapman, Varun M Kumar, Jonathan D Campbell

Pharmacoeconomics· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Summary from the Institute for Clinical and Economic Review's New England Comparative Effectiveness Public Advisory Council.
Ifeoma S Otuonye, Reiner Banken, Varun M Kumar, Steven D Pearson

J Manag Care Spec Pharm· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effectiveness and Value of Biologic Therapies for the Treatment of Uncontrolled Asthma.
Jeffrey A Tice, Jonathan D Campbell, Patricia G Synnott, Judith M E Walsh, Varun M Kumar

J Manag Care Spec Pharm· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Abuse Deterrent Formulations of Opioids in Patients With Chronic Pain in the United States: A Cost-Effectiveness Model.
Varun M Kumar, Foluso Agboola, Patricia G Synnott, Celia Segel, Maggie Webb

Value Health· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Survival and Cost-effectiveness Associated With Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell Lymphoma.
Melanie D Whittington, R Brett McQueen, Daniel A Ollendorf, Varun M Kumar, Richard H Chapman

JAMA Netw Open· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Value of Sarilumab Monotherapy for Adults with Moderately to Severely Active Rheumatoid Arthritis: A Cost-Effectiveness Analysis.
Melanie D Whittington, R Brett McQueen, Daniel A Ollendorf, Richard H Chapman, Varun M Kumar

J Manag Care Spec Pharm· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory Leukemia.
Melanie D Whittington, R Brett McQueen, Daniel A Ollendorf, Varun M Kumar, Richard H Chapman

JAMA Pediatr· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States.
Patrick M Zueger, Varun M Kumar, Rachel L Harrington, Gianna C Rigoni, Alicia Atwood

Pharmacotherapy· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Explaining variation in the uptake of HPV vaccination in England.
Varun M Kumar, David K Whynes

BMC Public Health· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis